Home
/

What is a Cystatin C Blood Test?

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Quick answer:

Cystatin C is a small protein produced steadily by all nucleated cells, freely filtered by the kidneys, and fully metabolized in the tubules, offering a muscle-independent estimate of glomerular filtration rate (eGFR) that is reliable across ages and body types. It detects early chronic kidney disease that creatinine may miss in elderly, frail, or malnourished individuals, and even mild eGFR reductions by cystatin C are associated with higher cardiovascular risk and mortality.

Read more →
Table of contents

A Muscle-Independent Marker of Glomerular Filtration

Cystatin C is a small protein that all your body's cells release into the bloodstream at a steady rate (cysteine protease inhibitor made by nucleated cells). The kidneys filter it out through the glomeruli, and the filtered protein is then taken up and broken down by the tubules, so it doesn't return to the blood. A Cystatin C blood test measures this protein and reports an estimated kidney filtering value (eGFR, estimated glomerular filtration rate) calculated from the cystatin C level.

Because production is steady and removal depends almost entirely on kidney filtration, blood cystatin C reflects how well your kidneys are filtering. Reporting eGFR alongside it translates that signal into an intuitive estimate of overall kidney filtering capacity (glomerular filtration rate). Compared with creatinine, cystatin C is less tied to muscle mass and typical diet, making it helpful across different ages and body types. In practice, it provides a clear, complementary view of kidney function and helps track changes over time.

Why Cystatin C Sharpens the Kidney Picture

Cystatin C is a small protein made by all cells and cleared almost entirely by the kidneys' filters. Measured together with the estimated glomerular filtration rate (eGFR), it gives a clear picture of how well your kidneys are cleansing the blood—affecting blood pressure, fluid balance, electrolytes, bone and red blood cell health, toxin and drug removal, and ultimately heart and brain function. Unlike creatinine, cystatin C is minimally influenced by muscle mass, diet, or sex, making it reliable across ages and body types.

Big picture: cystatin C with eGFR anchors kidney health to the cardiovascular and endocrine systems, refines chronic kidney disease staging beyond creatinine, and signals long-term risks for heart disease, stroke, and mortality even with mild declines in filtration.

Reading Cystatin C and Its eGFR

Typical cystatin C values sit in a narrow lab range; better kidney function shows values toward the lower end, with eGFR in the higher range. eGFR tends to be higher in children and during normal pregnancy, and it declines gradually with aging.

When cystatin C is low and eGFR is high, filtration is brisk. People usually feel well. This pattern is common in children and pregnancy, and can also reflect "hyperfiltration" states (for example, early diabetes or high cardiac output) that may precede later kidney strain. Low values usually reflect higher filtration (hyperfiltration) or lower cystatin C production rather than disease. They can appear in early pregnancy and with too little thyroid hormone (hypothyroidism). Unlike creatinine, low muscle mass does not falsely lower cystatin C.

Being in range suggests stable GFR and effective clearance of metabolic wastes, with steady electrolytes and blood pressure control. For most adults, values toward the lower end of the reference interval indicate robust filtration, appropriate for age and body size.

When cystatin C is high and eGFR is low, filtration is reduced. High values usually reflect reduced GFR from acute or chronic kidney impairment, signaling slower toxin clearance, fluid and electrolyte shifts, and higher cardiovascular risk. Waste and fluid accumulate, contributing to fatigue, swelling, shortness of breath, high blood pressure, nighttime urination, and foamy urine. Chronic reductions disrupt bone–mineral balance, erythropoietin and hemoglobin (anemia), and nerve function. In kids, long-standing impairment can affect growth; in pregnancy, cystatin C can rise despite increased GFR, so context matters. Levels can also rise independent of GFR with systemic inflammation, glucocorticoid exposure, obesity, smoking, and too much thyroid hormone (hyperthyroidism). Cystatin C tends to increase with age as filtration declines; in pregnancy, elevations may indicate complications that reduce GFR.

What Can Shift a Cystatin C Result

Notes: Cystatin C–based eGFR is less affected by muscle mass and does not require race adjustment. Equations that combine cystatin C with creatinine improve accuracy. Acute illness, assay differences, and medications (especially steroids and thyroid therapies) influence interpretation; correlate with creatinine, urinalysis, and clinical context.

FAQs

Cystatin C is a small protein produced at a steady rate by nearly all nucleated cells in the body. It is freely filtered by the kidneys’ glomeruli and almost entirely cleared from the blood through this process. Because its production is consistent and not significantly affected by muscle mass, diet, or body size, cystatin C serves as a reliable marker for kidney filtration efficiency. Measuring cystatin C, especially when used to calculate estimated glomerular filtration rate (eGFR), provides a more accurate assessment of kidney function, particularly in individuals where creatinine-based tests may be unreliable.

Cystatin C–based eGFR offers a more muscle-independent estimate of kidney function compared to creatinine-based eGFR. While creatinine levels can be influenced by muscle mass, diet, age, and sex, cystatin C is less affected by these factors. This makes cystatin C–based eGFR especially useful for older adults, children, and people with unusually high or low muscle mass. It provides a clearer picture of true kidney filtration capacity, helping to clarify kidney function when creatinine results are borderline or uncertain.

A cystatin C test is particularly valuable when creatinine-based eGFR results are borderline (e.g., 45–59 mL/min/1.73m²), or when muscle mass, age, or diet may make creatinine unreliable. It is also useful for confirming or ruling out chronic kidney disease, guiding medication dosing for drugs cleared by the kidneys, and assessing cardiovascular risk. Combining cystatin C with creatinine and urine albumin tests provides a more comprehensive view of kidney health.

Using cystatin C to assess kidney function offers several benefits: it provides a more accurate estimate of glomerular filtration rate (eGFR) independent of muscle mass, body size, or diet; it helps clarify kidney function in special populations like children and older adults; it improves chronic kidney disease staging; and it enables safer medication dosing. Additionally, cystatin C levels are linked to cardiovascular risk, allowing for earlier risk assessment and intervention.

Cystatin C is measured through a simple blood test. The result is often used to calculate an estimated glomerular filtration rate (eGFR), which quantifies how well the kidneys are filtering blood. “With eGFR” means the cystatin C value is incorporated into a standardized formula to estimate overall kidney filtering capacity, providing a single, interpretable number that reflects kidney health.

Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.

We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.

References

  1. Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., Crews, D. C., Doria, A., Estrella, M. M., Froissart, M., Grams, M. E., Greene, T., Grubb, A., Gudnason, V., Gutierrez, O. M., Kalil, R., Karger, A. B., Mauer, M., Navis, G., ... Levey, A. S. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. The New England Journal of Medicine, 385(19), 1737-1749. https://doi.org/10.1056/NEJMoa2102953
  2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 105(4S), S117-S314. https://doi.org/10.1016/j.kint.2023.10.018
  3. Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. L., Castro, A. F., 3rd, Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., & Coresh, J. (2009). A new equation to estimate glomerular filtration rate. Annals of Internal Medicine, 150(9), 604-612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006
  4. Gounden, V., Bhatt, H., & Jialal, I. (2024). Renal function tests. In StatPearls. StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/29939598/
  5. Hosten, A. O. (1990). BUN and creatinine. In H. K. Walker, W. D. Hall, & J. W. Hurst (Eds.), Clinical methods: The history, physical, and laboratory examinations (3rd ed.). Butterworths. https://pubmed.ncbi.nlm.nih.gov/21250147/

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey